Scanogen Inc

Scanogen Inc. is a privately held molecular diagnostic company based in Milford Mill, Maryland. The company employs five individuals and generates an annual revenue of $2.5 million. Scanogen is dedicated to revolutionizing healthcare by developing innovative systems capable of decoding the biomolecular information present in bodily fluids. Their core offering is Single MOLecule Tethering (SMOLT), a proprietary technology enabling rapid and highly sensitive detection of biomolecules. This technology underpins the development of a user-friendly, comprehensive diagnostic platform that streamlines the diagnostic process from sample collection to results. Scanogen's research and development efforts are primarily focused on two key areas: point-of-care diagnostics and the detection of bloodstream infections. The company has secured substantial funding from the National Institutes of Health (NIH), amassing a total of $9.5 million in grants to advance the development of its diagnostic assays. For inquiries or further information, please visit Scanogen's website at scanogen.com.